logo
Share SHARE
FONT-SIZE Plus   Neg

STADA Arzneimittel Increases FY19 Targets - Quick Facts

STADA Arzneimittel AG (STDAY.PK,STDAF.PK) announced its Executive Board increased the medium-term growth targets for the Group for 2019. The company now expects: adjusted Group sales of 2.65 to 2.70 billion euros (previously: about 2.60 billion euros); adjusted EBITDA in a range between 570 and 590 million euros (previously: about 510 million euros); and adjusted net income to increase to between 250 and 270 million euros (previously: about 250 million euros).

The Group said the increase in the medium-term growth targets for 2019 is a reflection of the interim results from the group wide "STADA Plus" program to improve performance that was introduced in the summer of 2016. Additional value enhancement potentials have also been identified as part of the strategy project that was launched at the beginning of the year.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
10 Worst Places To Raise A Family Whether you are a young couple building a nest or seasoned parents looking for a change of scenery, there are number of places around the country that should be avoided, according to personal finance website WalletHub. They looked at mainly five categories for... A passenger has filed a lawsuit against Canadian budget airline Sunwing Airlines for serving him cheap sparkling wine instead of champagne on board a flight, according to media reports. The Canadian passenger, Daniel MacDuff, reportedly boarded his Sunwing flight to Cuba in February, on a flight package that advertised a complimentary on-board champagne toast. Senate Health Committee Chairman Lamar Alexander, R-Tenn., and ranking member Patty Murray, D-Wash., announced Thursday that twenty-two other Senators are cosponsoring their bipartisan plan to provide short-term stability to Obamacare. The bipartisan bill includes a two-year extension of the cost-sharing...
comments powered by Disqus
Follow RTT